Novartis announced the sale of its Quebec sterile manufacturing facility as well as the adjacent Sandoz Development Center to CDMO Avara Pharmaceutical Services.
The Boucherville plant is the largest sterile manufacturing facility for injectable medicines in Canada, supplying injectable medicines to Sandoz in Canada and the United States.
Under the terms of the deal, Sandoz Canada remains the owner of the marketing authorizations for its products manufactured by Avara, and both parties will sign a long-term supply agreement to ensure that supply, quality and service remains unchanged.
For Avara, the acquisition represents its first entry into the Canadian market and further expands its sterile processing capability.
